Literature DB >> 23374187

cAMP biosensors applied in molecular pharmacological studies of G protein-coupled receptors.

Jesper Mosolff Mathiesen1, Line Vedel, Hans Bräuner-Osborne.   

Abstract

Cyclic adenosine monophosphate (cAMP) is a common second messenger that mediates numerous biological responses. Intracellular cAMP levels are increased by activation of G(s)-coupled G protein-coupled receptors (GPCRs) and decreased by activation of G(i)-coupled GPCRs via the adenylyl cyclase. Many end-point assays for quantifying GPCR-mediated changes in intracellular cAMP levels exist. More recently, fluorescence resonance energy transfer (FRET)-based cAMP biosensors that can quantify intracellular cAMP levels in real time have been developed. These FRET-based cAMP biosensors have been used primarily in single cell FRET microscopy to monitor and visualize changes in cAMP upon GPCR activation. Here, a similar cAMP biosensor with a more efficient mCerulean/mCitrine FRET pair is described for use in the 384-well plate format. After cloning and expression in HEK293 cells, the biosensor is characterized in the 384-well plate format and used for measuring the signaling of the G(s)-coupled β(2)-adrenergic receptor. The procedures described may be applied for other FRET-based biosensors in terms of characterization and conversion to the 384-well plate format.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374187     DOI: 10.1016/B978-0-12-407865-9.00011-X

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  5 in total

1.  Structure-Based Design and Discovery of New M2 Receptor Agonists.

Authors:  Inbar Fish; Anne Stößel; Katrin Eitel; Celine Valant; Sabine Albold; Harald Huebner; Dorothee Möller; Mary J Clark; Roger K Sunahara; Arthur Christopoulos; Brian K Shoichet; Peter Gmeiner
Journal:  J Med Chem       Date:  2017-11-13       Impact factor: 7.446

Review 2.  Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.

Authors:  Archana Shankar; Jaclyn W McAlees; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2022-08       Impact factor: 14.290

3.  Gs protein peptidomimetics as allosteric modulators of the β2-adrenergic receptor.

Authors:  Lotte-Emilie Boyhus; Mia Danielsen; Nina Smidt Bengtson; Micha Ben Achim Kunze; Xavier Kubiak; Tjerk J Sminia; Jacob Hartvig Løper; Phuong Thu Tran; Kresten Lindorff-Larsen; Søren G F Rasmussen; Jesper Mosolff Mathiesen; Daniel Sejer Pedersen
Journal:  RSC Adv       Date:  2018-01-09       Impact factor: 4.036

4.  A Focus on Unusual ECL2 Interactions Yields β2 -Adrenergic Receptor Antagonists with Unprecedented Scaffolds.

Authors:  Magdalena M Scharf; Mirjam Zimmermann; Florian Wilhelm; Raimond Stroe; Maria Waldhoer; Peter Kolb
Journal:  ChemMedChem       Date:  2020-04-17       Impact factor: 3.466

5.  The human G protein-coupled ATP receptor P2Y11 is a target for anti-inflammatory strategies.

Authors:  Georg Gruenbacher; Hubert Gander; Gabriele Dobler; Andrea Rahm; Dominik Klaver; Martin Thurnher
Journal:  Br J Pharmacol       Date:  2021-02-19       Impact factor: 9.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.